Replies to post #487710 on NorthWest Biotherapeutics Inc (NWBO)

[monentum2play]

https://www.astrazeneca.com/our-therapy-areas/oncology/medicines-portfolio-and-pipeline.html

Astrazeneca is in the oncology like most drug companies

[biosectinvestor]

Exactly right. And AZ is not the best company in oncology and doesn’t necessarily have the wherewithal to pay top dollar. This is where investors like Woodford put their own interests over the shareholders in NWBO. He likely held a large interest in AZ and thought buying NWBO CHEAP would suddenly put them in the ballgame to compete with Merck.

Investors need to be wary of such “white knights”.

[dmb2]

It would be necessary to understand the BP's R&D strategy in addition to their current product portfolio, which may be to buy the technology, the science and/or their expertise they require to move forward or to jump ahead in a therapeutic space. NWBO does not offer deep company expertise but does offer some science and significant technology to a potential suitor who sees the need and the fit.